Back to search

Article

Disease-modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer’s disease mouse model : A Comparative study with donepezil

2020-12-19

Abstract excerpt

<h4>Background: </h4> and Purpose: The development of effective therapeutic strategies against Alzheimer’s disease (AD) remains a challenge. I2 Imidazoline receptors (I2-IR) ligands have a neuroprotective role in AD. While co-treatment of acetylcholinesterase inhibitors with neuroprotective agents have shown better effects on the prevention of dementia. Here, we assessed the potential therapeutic effect of the I2-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1d6cb557-5051-58ef-91d8-d903999733f2
DOI
10.22541/au.160837544.42503419/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Disease-modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer’s disease mouse model : A Comparative study with donepezilDOI 10.22541/au.160837544.42503419/v1
Riluzole reduces amyloid beta pathology, improves memory, and restores gene expression changes in a transgenic mouse model of early-onset Alzheimer’s diseaseSemantic proximity
Identification and drug-induced reversion of molecular signatures of Alzheimer’s disease onset and progression in <i> App <sup>NL-G-F</sup> </i> , <i> App <sup>NL-F</sup> </i> and 3xTg-AD mouse modelsSemantic proximity
Co-treatment With the Herbal Medicine SIP3 and Donepezil Improves Memory and Depression in the Mouse Model of Alzheimer’s DiseaseSemantic proximity
A Novel multifunctional 5,6-dimethoxy-indanone-chalcone-carbamate hybrids alleviates cognitive decline in Alzheimer’s disease by dual inhibition of acetylcholinesterase and inflammationSemantic proximity
Discovery of a CI-994 derivative as a dual modulator of class I HDACs and Wnt/β-catenin signaling for Alzheimer’s disease therapySemantic proximity
Riluzole: a therapeutic strategy in Alzheimer’s disease by targeting the WNT/β-catenin pathwaySemantic proximity
Histone deacetylase inhibition mitigates cognitive deficits and astrocyte dysfunction induced by Aβ oligomersSemantic proximity
Liver-X receptor β-selective agonist CE9A215 regulates Alzheimer’s disease- associated pathology in a 3xTg-AD mouse modelSemantic proximity
Histone Deacetylase Inhibition in Alzheimer’s Disease: Molecular Mechanisms, Therapeutic Potential, and Future PerspectivesSemantic proximity
Diazoxide/dibenozylmethane treatment mitigates spatial memory deficits and pathology and upregulates protective genes in an Alzheimer’s transgenic rat modelSemantic proximity
Riluzole shifts glial responses to protect synapses and memory in Aβ oligomer–treated ratsSemantic proximity
Pharmacological modulation of glutamatergic and neuroinflammatory pathways in a Lafora disease mouse modelSemantic proximity
Select a neighboring publication to make it the new centre.